Abstract 4142: CD4 T cell-driven response to immunotherapy against mouse melanoma tumors
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4142
Abstract: Using an in situ vaccine (ISV) regimen that includes a combination therapy of radiation (given at D0) with hu14.18-IL2 immunocytokine [anti-GD2 linked to IL2, (Anyxis Immuno-Oncology GmbH (Austria)); given at D5-D9], we can cure mice… read more here.
Keywords: cell; cd4 cells; b78; melanoma tumors ... See more keywords